Senior insider sale
President and CEO at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$9.16M
108.27K shares
What this filing means
PATEL DINESH V PH D plans to sell 108.27K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $9.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0001968582-26-000059
DirectorOfficer· President and CEO
Since Jul 2018
108.27K
Shares to sell
$9.16M
Approx. market value
108.27K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Option Exercise
Cash
1/23/2026
78.27KOption Exercise
Cash
1/23/2026
30KTotal acquired108.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | Option Exercise Cash | 78.27K | — |
1/23/2026 | Option Exercise Cash | 30K | — |
| Total | 108.27K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
108.27K
Market value
$9.16M
1/23/2026
Total
Units
108.27K
Value
$9.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/23/2026 | 108.27K | $9.16M | Nasdaq | Planned |
| Total | 108.27K | $9.16M | ||